| Trial ID: | L6563 |
| Source ID: | NCT01789788
|
| Associated Drug: |
Placebo
|
| Title: |
A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Placebo|DRUG: RO6811135
|
| Outcome Measures: |
Primary: Safety: Incidence of adverse events, approximately 5 months | Secondary: Pharmacokinetics: Area under the concentration-time curve (AUC), Day 1 and Day 14|Pharmacodynamics of RO681135: Blood analysis, 14 days
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
56
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-03
|
| Completion Date: |
2013-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-02
|
| Locations: |
Chula Vista, California, 91911, United States|Cincinnati, Ohio, 45227, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01789788
|
